Thromboembolic Events in the Hemodialysis Setting: Understanding Risk Profiles and Cumulative Incidences to Inform Clinical Trial Design

Background People with kidney failure have a high risk of cardiovascular morbidity/death, including thromboembolic events. Factor XIa inhibitors are a new class of anticoagulants in development that may offer antithrombotic benefits with a lower risk of incremental bleeding events than traditional t...

Full description

Saved in:
Bibliographic Details
Main Authors: Angelo Karaboyas, Junhui Zhao, Laszlo B. Tanko, Kristian Tore Joergensen, Akos F. Pap, Indranil Dasgupta, Masaomi Nangaku, Michel Jadoul, Roberto Pecoits‐Filho
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.033983
Tags: Add Tag
No Tags, Be the first to tag this record!